2Hunt SA,Baker DW,Chin MH,et al.ACC/ AHA Guidelines for the evaluation and management of chronic heart failure in the adult:executive summarya report of the American college of cardiology/ American heart association taskforce on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure)[J].Circulation,2001,104:2996.
3The Digitalis Investigation Group.The effect of digoxin on mortality and morbidity in patients with heart failure[J].N Engl J Med,1997,336:525.
4Rathore SS,Curtis JP,Wang Y,et al.Association of serum digoxin concentration and outcomes in patients with heart failure[J].JAMA,2003,289:871-878.
5Adams KF Jr,Gheorghiade M,Uretsky BF,et al.Clinical benefits of low serum digoxin concentration in heart failure[J].J Am Coll Cardiol,2002,39:946-953.
6Cohn JN,Goldstein SO,Greenberg BH,et al.for the Vesnarinone Trial Investigators.A dose-dependent increase inmortality with vesnarinone among patients with serve heart failure[J].N Engl J Med,1998,339:1810-1816.
7van Veldhuisen DJ,Man in,Veld A J,et al.Double-blind placebo-controlled study df ibopamine and digoxin in patients with mild to moderate heart failure:results of the Dutch Ibopamine Multicenter Trial (DIMT)[J].J Am Coll Cardiol,1993,22:1564 -1573.
8Follath F,Cleland JGF,Just H.Efficacy and safety of intravenous levosimendan,a novel calcium sensitiser,in serve low output faiure (the LIDO study)[J].Lancet,2002,360(9328):196 -202.
9Zairis MN,Apostolatos,Anastasiadis P,et al.The effect of a calcium sensitiser or an inotrope or none in chornic low output decompensated heart faiure:results from the calcium sensitiser or an inotrope or none in chornic low output heart faiure study (CASINO)[J].J Am Coll Cardiol,2004,43 (5):206A-207A.
10Cleland JG,Ghosh J,Freemantle N,et al.Clinical trials update and cumulative meta analyses from the American College of Cardiology:WATCH,SCD-HeFT,DNAM Ⅱ,CASINO,INSP IRE,STRATUS-US,and cardiac resyn chronisation therapy in heart failure[J].Eur J Heart Fail,2004,6 (4):501 -508.
